EFFICACY AND SAFETY OF NALMEFENE IN PATIENTS WITH SEVERE PRURITUS CAUSED BY CHRONIC URTICARIA AND ATOPIC-DERMATITIS

被引:89
作者
MONROE, EW
机构
关键词
D O I
10.1016/S0190-9622(89)80353-6
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:135 / 136
页数:2
相关论文
共 6 条
[1]   CONTROLLED ANTIPRURITIC TRIAL OF NALMEFENE (N) IN CHRONIC URTICARIA (CU) AND ATOPIC-DERMATITIS [J].
BANERJI, D ;
FOX, R ;
SELEZNICK, M ;
LOCKEY, R .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (01) :252-252
[2]  
BERNSTEIN J E, 1979, Archives of Dermatology, V115, P1366, DOI 10.1001/archderm.115.11.1366
[3]   ANTI-PRURITIC EFFECT OF AN OPIATE ANTAGONIST, NALOXONE HYDROCHLORIDE [J].
BERNSTEIN, JE ;
SWIFT, RM ;
SOLTANI, K ;
LORINCZ, AL .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 78 (01) :82-83
[4]  
MICHEL ME, 1985, METHOD FIND EXP CLIN, V7, P175
[5]   NALOXONE, ITCH, ASTHMA, URTICARIA, AND ANGIOEDEMA [J].
SMITZ, S ;
LEGROS, JJ .
ANNALS OF INTERNAL MEDICINE, 1982, 97 (05) :788-789
[6]   NALOXONE MODULATES THE PERCEPTION OF ITCH IN MAN [J].
SUMMERFIELD, JA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (02) :180-183